GEORGE A. OMURA, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Campling and colleagues (1) on the basis of a review of their own material, do not recommend bone marrow examination as part of the routine staging of small cell lung cancer. However, as treatment of this type of cancer improves, accurate staging may become more important. In the meantime, it should be kept in mind that a positive bone marrow specimen provides histologic documentation of disseminated disease. The other studies commonly used may provide radiographic or chemical evidence of disseminated disease but are subject to misinterpretation, overinterpretation, and so on. Thus, the bone marrow examination should not
OMURA GA. Bone Marrow Examination in Small Cell Lung Cancer. Ann Intern Med. 1987;106:170–171. doi: https://doi.org/10.7326/0003-4819-106-1-170_2
Download citation file:
Published: Ann Intern Med. 1987;106(1):170-171.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use